Respiratory Flashcards
Asthma
paroxysmal and reversible obstruction of airways - involves bronchospasm and excessive production of secretions
Asthma patho
narrowing of airway, SM contraction, airway wall thickening by cellular infiltration, inflammation, secretions
Eosinophilic - associated with allergy, subset of atopic/non-atopic
Non-eosinophilic - later onset, overlaps with smoking, obesity, neutrophils instead of eosinophils
RFs
FHx, atopy, low SES, inner city environ, obesity, premature, viral infections in early childhood, smoking
Asthma Px
symptoms intermittent SOB wheeze cough (often nocturnal) sputum chest tightness
signs tachypnoea audible wheeze - widespread, polyphonic hyperinflated chest hyper-resonant percussion note reduced air entry
Levels of acute asthma atttack
Moderate
increasing symptoms
PEF >50-75%
no features of severe attack
Severe cannot complete sentences HR >110 RR >25 PEF 33-50% predicted
Life-threatening silent chest confusion exhaustion cyanosis bradyacardia PEF <33% Sats <92% hypotension
Near fatal
PaCO2 increase
Asthma DDx
COPD
later disease, smokers
more relentless progressive SOB with wheeze, less diurnal variation
winter symptoms, sputum production
fibrosis - would have crackles
bronchiolitis, bronchiectasis, CF, PE, bronchial obstruction, CCF, pneumothorax, PO, viral infections…
Asthma Ix
Blood count - eosinophils
Atopy/allergy (SPT, RAST)
CXR
Spirometry / peak flow
Reduced FEV1, FEV1/FVC <70%
PEFR reduced, >20% variability
FeNO test
level of NO in breath - measure of inflammation
BDR test (bronchodilator reversibility) see if obstruction gets better with bronchodilator medication
Direct bronchial challenge
see if breathing worsens worsens with provocation agent (methacholine/histamine)
Asthma Mx
Stop smoking, avoid precipitants, wt loss, monitor PEF
BTS guidelines
1 - SABA (salbutamol)
2 - ICS (beclometasone)
3 - LABA (salmeterol), maybe leukotriene receptor antagonist, theophylline
4 - higher dose ICS, with previous therapy
5 - oral prednisolone
omalizumab - anti-IgE Mab for persistent allergic asthma
Acute attack Assess severity - PEF, ability to speak, RR, HR, sats O2 Salbutamol Ipratropium if severe Hydrocortisone/prednisolone Reassess every 15 mins ECG Magnesium sulfate if not responding
Bronchiectasis
permanent dilatation and thickening of bronchi and bronchioles after chronic inflammation
Bronchiectasis patho
diffuse/local
characterised by chronic cough, excessive sputum, bacterial colonisation, recurrent acute infections
Main orgs - H.influenzae, Strep.pneumoniae, Staph.aureus, Pseudomonas aeruginosa
Results from chronic pulmonary inflammation, scarring, mucociliary transport mechanism impaired, impairment of immune function
Causes - congenital, post-infection, other (bronchial obstruction, allergic bronchopulmonary aspergillosis (ABPA), RA, UC)
Bronchiectasis Px
signs
finger clubbing
coarse inspiratory crepitations
wheeze (asthma, COPD, ABPA)
symptoms persistent cough SOB copious purulent (khaki coloured) sputum intermittent haemoptysis chest pain
Bronchiectasis DDx
CF, asthma, TB, pneumonia, cancer
Bronchiectasis Ix
Sputum culture, bloods
CXR - cystic shadows, thickened bronchial walls, abnormal dilatation
HRCT - dilated, thickened bronchi, signet ring sign
Spirometry - obstruction
Bronchoscopy
Serum Igs, CF sweat test, SPT, RAST
Bronchiectasis Mx
Healthy diet, stop smoking
Airway clearance techniques - postural drainage, chest physio
ABs
P.aeruginosa - ciprofloxacin
H.influenzae - amoxicillin, co-amoxiclav, doxycycline
S.aureus - flucloxacillin
Salbutamol
Anti-inflammatory - eg azithromycin
Surgery - if disease is localised, or to control haemoptysis
Bronchiectasis Cx
pneumonia, pleural effusion, pneumothorax, haemoptysis
COPD
progressive respiratory disorder characterised by airflow obstruction - airway/parenchymal damage
obstruction = FEV1/FVC <0.7
Resp drive normally PaCO2 driven, but in COPD, hypoxia can be a strong drive, so resp drive can be reduced if hypoxia is corrected
COPD patho
Small airways disease - chronic bronchitis
airway inflammation, fibrosis, luminal plugs, increased airway resistance, cough, sputum production
Parenchymal destruction - emphysema
loss of alveolar attachments, decrease of elastic recoil, alveolar wall destruction
Vascular changes
V/Q mismatch, low PaO2, high PaCO2, pul HTN may result
A1AT deficiency
A1AT is a protease inhibitor, normally protects tissues from enzymes from inflammatory cells (neutrophil elastase -> loss of recoil)
Causes
smoking, air pollution, occupational exposure
RFs
male, older, asthma, A1AT deficiency, low SES, HIV
COPD Px
signs tachypnoea use of accessory muscles of resp (might lean forward) hyperinflation (barrel shaped chest) decreased expansion resonant/hyper-resonant percussion note expiration through pursed lips quiet breath sounds cyanosis cor pulmonale, peripheral oedema, raised JVP cachexia
symptoms SOB cough sputum wheeze minimal diurnal variation wt loss
PP vs BB
PP - increased alveolar ventilation, normal PaO2, breathless, not cyanosed
BB - decreased alveolar ventilation, low PaO2, high PaCO2, cyanosed, not breathless, resp centres insensitive to CO2, rely on hypoxic drive
COPD DDx
Asthma, HF, other causes of SOB, PE, pneumonia, lung cancer, bronchiectasis, TB
COPD / asthma? age usually younger in asthma smoking history - in most with COPD SOB variable in asthma nocturnal symptoms more common in asthma persistent productive cough common in COPD, not asthma
COPD Ix
Spirometry - FEV1/FVC < 0.7, FEV1 < 80%
CXR - hyperinflation, flat hemidiaphragms, large central pulmonary arteries, bullae
CT - bronchial wall thickening, scarring, air space enlargement
ECG - cor pulmonale
ABG - decreased PaO2 +/- hypercapnia
FBC - identify anaemia / polycythaemia
MRC SOB scale, NICE COPD severity classification
COPD Mx
Stop smoking, influenza and pneumonia vaccines, pulmonary rehab
Bronchodilators SABA - salbutamol LABA - salmeterol, formoterol SAMA - ipratropium LAMA - tiotropium Theophylline - bronchodilator, suppresses airway response to stimuli
ICS - beclometasone, fluticasone
Combination therapy of above
Oxygen therapy
NIV (non-invasive ventilation)
Phosphodiesterase t4 inhibitors - anti-inflammatory - eg roflumilast
Mucolytics
Surgery - bullectomy, lung volume reduction surgery, transplant
OVERALL
- SABA / SAMA
- If steroid responsive / asthmatic = add LABA + ICS
- If not steroids responsive / non-asthmatic = add LABA + LAMA
- Oral theophylline
- Long term oxygen therapy
Do not prescribe LAMA and SAMA together, if started on LAMA, remove SAMA
COPD Cx
Acute exacerbation, infection secondary polycythaemia (not enough O2 reaching tissues, EPO increases) resp failure pneumothorax lung carcinoma reduced QoL
COPD acute exacerbation
acute worsening of symptoms
commonly viral cause, also bacterial, air pollutants
Tx - nebulised bronchodilators, O2, steroids, ABs, aminophylline/theophylline, doxapram (respiratory stimulant drug), NIV
CF
autosomal recessive multi-organ disease, resp problems, pancreatic insufficiency, characterised by thickened secretions
CF patho
mutations in CFTR gene (chromosome 7) - chloride channel exporting Na and Cl
defective -> not enough Cl secretion, increased Na absorption, less water secreted -> thickened secretions
(in sweat gland, cannot reabsorb Cl, thus Na also not reabsorbed)
- High sodium sweat
- Pancreatic insufficiency - dehydration of secretions, they stagnante in ducts
- Biliary disease - concentrated bile, plugging, local damage
- GI disease - highly viscous secretions, intraluminal water deficiency
- Resp disease - dehydration of airway surfaces, reduced mucociliary clearance, favours bacteria, inflammatory lung damage
RFs - FHx